Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Medical News

Medical News Prophylactic cancer chemotherapy may have first trials soon The first clinical trials in cancer chemoprevention could begin within a year under the auspices of the National Cancer Institute (NCI), in Bethesda, Md. The idea of cancer chemoprevention is to use pharmacologic means to stop or reverse preneoplastic changes in tissue before the ultimate progression to tumor formation becomes irreversible. The principal chemical to be tested could be 13-cis-retinoic acid, a synthetic analog of vitamin A, that would be administered to persons at high risk of cancer. "I think there are people in the United States at sufficiently high risk of cancer that one could justifiably consider the possibility of putting them on a regimen of 13-cis-retinoic acid on a prophylactic basis," says Michael B. Sporn, MD, chief of the Lung Cancer Branch at NCI. Among the possible candidates for such treatment are asbestos workers and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Medical News

JAMA , Volume 235 (14) – Apr 5, 1976

Loading next page...
 
/lp/american-medical-association/medical-news-LpoDmI02MK

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1976 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1976.03260400003001
Publisher site
See Article on Publisher Site

Abstract

Prophylactic cancer chemotherapy may have first trials soon The first clinical trials in cancer chemoprevention could begin within a year under the auspices of the National Cancer Institute (NCI), in Bethesda, Md. The idea of cancer chemoprevention is to use pharmacologic means to stop or reverse preneoplastic changes in tissue before the ultimate progression to tumor formation becomes irreversible. The principal chemical to be tested could be 13-cis-retinoic acid, a synthetic analog of vitamin A, that would be administered to persons at high risk of cancer. "I think there are people in the United States at sufficiently high risk of cancer that one could justifiably consider the possibility of putting them on a regimen of 13-cis-retinoic acid on a prophylactic basis," says Michael B. Sporn, MD, chief of the Lung Cancer Branch at NCI. Among the possible candidates for such treatment are asbestos workers and

Journal

JAMAAmerican Medical Association

Published: Apr 5, 1976

There are no references for this article.